Start-ups and tech giants are the future of pharma marketingWe are living in a revolutionary time of scientific change and innovation in pharma marketing – and the Share XStart-ups and tech giants are the future of pharma marketinghttps://pharmaphorum.com/sales-marketing/start-ups-and-tech-giants-are-the-future-of-pharma-marketing/
Betsy Bondurant joins 3Sixty Event Consulting to lead US operationsSpecialist project management consultancy today announced Betsy Bondurant as its new Head of US Operations. Effective immediately Betsy Share XBetsy Bondurant joins 3Sixty Event Consulting to lead US operationshttps://pharmaphorum.com/partner-content/appointments/betsy-bondurant-joins-3sixty-event-consulting-to-lead-us-operations/
Indivior’s once-monthly schizophrenia injection gets US green lightRegulators authorities in the US have approved Indivior’s long-acting injectable treatment for adults with schizophrenia. Perseris (risperidone) won Share XIndivior’s once-monthly schizophrenia injection gets US green lighthttps://pharmaphorum.com/news/indivior-schizophrenia-perseris-fda/
FDA refuses to approve Insys opioid painkillerThe US regulators have rejected Insys Therapeutics’ opioid-based painkiller because of concerns about its safety. The FDA knock-back Share XFDA refuses to approve Insys opioid painkillerhttps://pharmaphorum.com/news/fda-insys-therapeutics-opioid-painkiller/
Bayer hits back at Netflix medical device documentaryBayer has issued a robust defence of Essure after the birth control implant was featured in The Bleeding Share XBayer hits back at Netflix medical device documentaryhttps://pharmaphorum.com/news/bayer-netflix-essure-safety/
J&J tops the pharma market cap charts – but for how long?Data and analytics firm GlobalData has tracked the market cap and performance of the top 25 pharma companies Share XJ&J tops the pharma market cap charts – but for how long?https://pharmaphorum.com/views-and-analysis/jj-tops-pharma-market-cap-charts-long/
New drugs boost Eli Lilly, ahead of animal health IPOEli Lilly closed the second quarter with substantial revenue increase thanks to a strong performance from a group Share XNew drugs boost Eli Lilly, ahead of animal health IPOhttps://pharmaphorum.com/news/lilly-charges-revenue-increase/
GCP Inspection Readiness ConferenceGCP Inspection Readiness is taking place in Brussels, Belgium from 20th – 22nd November 2018. The conference is Share XGCP Inspection Readiness Conferencehttps://pharmaphorum.com/events/gcp-inspection-readiness-conference/
SMi’s Exclusive Interview with MedImmune Principal Scientist just releasedAn exclusive interview with Dr. Antonio DiGiandomenico, Principal Scientist, MedImmune has been released SMi Reports: An exclusive interview Share XSMi’s Exclusive Interview with MedImmune Principal Scientist just releasedhttps://pharmaphorum.com/partner-content/smis-exclusive-interview-with-medimmune-principal-scientist-just-released/
